(Q37849455)

24 August 2017

1 reference

title

Critical appraisal of animal models of multiple sclerosis (English)

1 reference

24 August 2017

0 references

David Baker

1

1 reference

24 August 2017

Wouter Gerritsen

series ordinal

2

1 reference

24 August 2017

Jon Rundle

series ordinal

3

1 reference

24 August 2017

Sandra Amor

series ordinal

4

1 reference

24 August 2017

3 March 2011

1 reference

Multiple Sclerosis Journal

24 August 2017

1 reference

24 August 2017

17

1 reference

24 August 2017

647-657

1 reference

24 August 2017

6

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

24 August 2017

1 reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Improving the translational hit of experimental treatments in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

The origin and application of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Animal models of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Mouse models for multiple sclerosis: historical facts and future implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Animal models of multiple sclerosis--potentials and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Experimental models of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Biozzi mice: of mice and human neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Building different mouse models for human MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Exploring the roles of CD8(+) T lymphocytes in the pathogenesis of autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

The value of animal models for drug development in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Anti-Abeta: The good, the bad, and the unforeseen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

The relevance of animal models in multiple sclerosis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Protection against experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Suppression of experimental allergic encephalomyelitis by mitoxantrone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Cannabinoids control spasticity and tremor in a multiple sclerosis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Lost in translation: bumps in the road between bench and bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Mononuclear cell trafficking and plasma protein extravasation into the CNS during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Axonal degeneration and progressive neurologic disability in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Pathogenesis of axonal and neuronal damage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Inhibitory role for GABA in autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

EAE: an immunologist's magic eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Lessons from multiple sclerosis: models, concepts, observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Inhibition of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Potential role of humoral immunity in the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Review of progressive multifocal leukoencephalopathy and natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Axonal protective effects of the myelin-associated glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

High Incidence of Spontaneous Disease in an HLA-DR15 and TCR Transgenic Multiple Sclerosis Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511398885

21 January 2018

Identifiers

DOI

10.1177/1352458511398885

1 reference

24 August 2017

1 reference